Online ISSN: 2582-5062
Current Trends in Pharmacy and Pharmaceutical Chemistry is the official Journal of Ateos Foundation of Science Education and Research, hosted and Managed IP Innovative Publications Pvt. Ltd, New Delhi, India. Current Trends in Pharmacy and Pharmaceutical Chemistry is an open access, peer-reviewed quarterly international journal publishing since 2019 and is published under auspices of the Ateos Foundation of Science Education and Research. It aims to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. more...Original Article
Author Details :
Volume : 6, Issue : 1, Year : 2024
Article Page : 18-22
https://doi.org/10.18231/j.ctppc.2024.004
Abstract
The present research work discusses the development and validation of a UV spectrophotometric method for ornidazole. Simple, accurate and cost efficient spectrophotometric method has been developed for the estimation of ornidazole in pure drug form. The optimum conditions for the analysis of the drug were established. The maximum wavelength (? max) was found to be 430 nm. Beers law was obeyed in the concentration range of 1?g/mL. Calibration curves shows a linear relationship between the absorbance and concentration. Validation was performed according to ICH guidelines for Linearity, accuracy, precision, LOD (limit of detection) and LOQ (limit of quantification). The sample solution was stable up to 36 hours. The proposed method may be suitable for the analysis of ornidazole in drug formulation for quality control purposes.
Keywords: Pharmacopoeia, Ornidazole, LOQ (limit of quantification)
How to cite : Welsingh M J, Arulappa R X, Shankarananth V, Analytical method development and validation of ornidazole by using uv spectroscopy. Curr Trends Pharm Pharm Chem 2024;6(1):18-22
This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.